Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy

References

• BruixJGoresGJMazzaferroVHepatocellular carcinoma: clinical frontiers and perspectivesGut201463584485524531850
   PubMed Web of Science ®Google Scholar
• YangJDRobertsLRHepatocellular carcinoma: A global viewNat Rev Gastroenterol Hepatol20107844845820628345
   PubMed Web of Science ®Google Scholar
• VenookAPPapandreouCFuruseJde GuevaraLLThe incidence and epidemiology of hepatocellular carcinoma: A global and regional perspectiveOncologist201015Suppl 4513
   PubMed Web of Science ®Google Scholar
• GuoYWangJZhangLTheranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinomaHepatology20166341240125526680504
   PubMed Web of Science ®Google Scholar
• HenryJCMalhotraLKhabiriHBest radiological response to trans-arterial chemoembolization for hepatocellular carcinoma does not imply better outcomesHPB (Oxford)201315319620223374360
   PubMed Web of Science ®Google Scholar
• AvilaMABerasainCSangroBPrietoJNew therapies for hepatocellular carcinomaOncogene200625273866388416799628
   PubMed Web of Science ®Google Scholar
• CoburnGACullenBRsiRNAs: A new wave of RNA-based therapeuticsJ Antimicrob Chemother200351475375612654731
   PubMed Web of Science ®Google Scholar
• CastanottoDRossiJJThe promises and pitfalls of RNA-interference-based therapeuticsNature2009457722842643319158789
   PubMed Web of Science ®Google Scholar
• PecotCVCalinGAColemanRLLopez-BeresteinGSoodAKRNA interference in the clinic: Challenges and future directionsNat Rev Cancer2011111596721160526
   PubMed Web of Science ®Google Scholar
• ShuYPiFSharmaAStable RNA nanoparticles as potential new generation drugs for cancer therapyAdv Drug Deliv Rev201466748924270010
   PubMed Web of Science ®Google Scholar
• MaPCMaulikGChristensenJSalgiaRc-Met: Structure, functions and potential for therapeutic inhibitionCancer Metastasis Rev200322430932512884908
   PubMed Web of Science ®Google Scholar
• Kaposi-NovakPLeeJSGòmez-QuirozLCoulouarnCFactorVMThorgeirssonSSMet-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeJ Clin Invest200611661582159516710476
   PubMed Web of Science ®Google Scholar
• FurgeKAZhangYWVandeWGMet receptor tyrosine kinase: Enhanced signaling through adapter proteinsOncogene200019495582558911114738
   PubMed Web of Science ®Google Scholar
• CorsoSComoglioPMGiordanoSCancer therapy: Can the challenge be MET?Trends Mol Med200511628429215949770
   PubMed Web of Science ®Google Scholar
• MokHZhangMSuperparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeuticsExpert Opin Drug Deliv2013101738723199200
   PubMed Web of Science ®Google Scholar
• MidouxPBreuzardGGomezJPPichonCPolymer-based gene delivery: A current review on the uptake and intracellular trafficking of polyplexesCurr Gene Ther20088533535218855631
   PubMed Web of Science ®Google Scholar
• SatoATakagiMShimamotoAKawakamiSHashidaMSmall interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in miceBiomaterials20072871434144217141864
   PubMed Web of Science ®Google Scholar
• PaoliniMPoulLBerjaudCNano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxelInt J Nanomedicine2017125537555628814868
   PubMed Web of Science ®Google Scholar
• AkincAThomasMKlibanovAMLangerRExploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesisJ Gene Med20057565766315543529
   PubMed Web of Science ®Google Scholar
• ur RehmanZHoekstraDZuhornISMechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: Real-time visualization of transient membrane destabilization without endosomal lysisACS Nano2013753767377723597090
   PubMed Web of Science ®Google Scholar
• BrombergLDiaoYWuHSpeakmanSAHattonTAChromium(III) terephthalate metal organic framework (MIL-101): HF-free synthesis, structure, polyoxometalate composites, and catalytic propertiesChem Mater201224916641675
   Web of Science ®Google Scholar
• OkadaMShiYBCell proliferation analysis during xenopus metamorphosis: Using 5-ethynyl-2-deoxyuridine (EdU) to stain proliferating intestinal cellsCold Spring Harb Protoc20179696700
   Google Scholar
• ColeAJDavidAEWangJGalbNCJYangVCMagnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticlesBiomaterials201132266291630121684593
   PubMed Web of Science ®Google Scholar
• LiuXSunCYangXWangJPolymeric-micelle-based nanomedicine for siRNA deliveryPart Part Syst Char2013303211228
   Web of Science ®Google Scholar
• XieBXingRChenPDown-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interferenceJ Surg Res2010162223123819765730
   PubMed Web of Science ®Google Scholar
• ShaoDLiJZhengXJanus “nano-bullets” for magnetic targeting liver cancer chemotherapyBiomaterials201610011813327258482
   PubMed Web of Science ®Google Scholar
• AmjadMWAminMCIMKatasHButtAMKesharwaniPIyerAKIn vivo antitumor activity of folate-conjugated cholic acid-polyethylenimine micelles for the codelivery of doxorubicin and siRNA to colorectal adenocarcinomasMol Pharm201512124247425826567518
   PubMedGoogle Scholar
• AramiSMahdaviMRashidiMRFathiMHejaziMSamadiNNovel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancerBiologicals201644648749627712979
   PubMed Web of Science ®Google Scholar
• LipkaJSemmler-BehnkeMWenkABurkhardtJAignerAKreylingWBiokinetic studies of non-complexed siRNA versus nano-sized PEI F25-LMW/siRNA polyplexes following intratracheal instillation into miceInt J Pharm20165001–222723526802492
   PubMedGoogle Scholar
• JiMLiPShengNSialic acid-targeted nanovectors with phenylboronic acid-grafted polyethylenimine robustly enhance siRNA-based cancer therapyACS Appl Mater Interfaces20168159565957627007621
   PubMed Web of Science ®Google Scholar
• ChenYZhuXZhangXLiuBHuangLNanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapyMol Ther20101891650165620606648
   PubMed Web of Science ®Google Scholar
• LiuJChiangTLiuCDelivery of siRNA using CXCR4-targeted nanoparticles modulates tumor microenvironment and achieves a potent antitumor response in liver cancerMol Ther201523111772178226278330
   PubMed Web of Science ®Google Scholar
• ChertokBDavidAEYangVCPolyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administrationBiomaterials201031246317632420494439
   PubMed Web of Science ®Google Scholar
• PanBCuiDShengYDendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery systemCancer Res200767178156816317804728
   PubMed Web of Science ®Google Scholar
• SuzukiKHayashiNYamadaYExpression of the c-met protooncogene in human hepatocellular carcinomaHepatology1994205123112367927256
   PubMed Web of Science ®Google Scholar
• DaveauMScotteMFrançoisAHepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinomaMol Carcinog200336313014112619035
   PubMed Web of Science ®Google Scholar
• ApparaillyFJorgensenCsiRNA-based therapeutic approaches for rheumatic diseasesNat Rev Rheumatol201391566223090506
   PubMed Web of Science ®Google Scholar
• OpitzLSalinas-RiesterGGradeMImpact of RNA degradation on gene expression profilingBMC Med Genomics201033620696062
   PubMed Web of Science ®Google Scholar
• KilkennyCBrowneWJCuthillICEmersonMAltmanDGImproving bioscience research reporting: the ARRIVE guidelines for reporting animal researchPLoS Biol201086e100041220613859
   PubMed Web of Science ®Google Scholar